Event Details

Cambia Grove, host Lee Huntsman, and series partner UW BioEngage are pleased to welcome Hans Bishop, former CEO of Juno Therapeutics. Hans will share his experience growing Juno from a spinoff out of the Fred Hutchinson Cancer Research Center, to a major biotech company employing more than 500 people before being acquired by Celgene for $9 billion.

The conversation will touch upon the disruptive trends Hans sees in the health care system, his advice on growing a startup, and reflections on how the current health care system is built for technologies of the past.